26 February 2025FeaturesPatentsCristen Corry, Paul Ainsworth and Uma Everett

Fed Circ ruling opens ITC door to small corporations

A decision in Wuhan Healthgen Biotech v ITC means smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler. 

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
11 January 2024   Court's ruling reinforces the PTAB's decision that two claims in Masimo's patent for blood oxygen measurement technology are unpatentable | Decision significant in the context of Apple's recent injunction at the US ITC and the ongoing dispute concerning Apple Watch tech.